BMD May Be Decreased Post-Transplant
Bone mineral density (BMD) may be reduced and parathyroid hormone (PTH) levels elevated in long-term renal transplant patients with good graft function, according to Swedish researchers.
Bone mineral density (BMD) may be reduced and parathyroid hormone (PTH) levels elevated in long-term renal transplant patients with good graft function, according to Swedish researchers.
Patients with intermediate-risk prostate cancer may be effectively treated with brachytherapy without supplemental pelvic radiotherapy, according to new findings.
Treatment with rapamycin may be associated with myoglobinuria and severe acute renal failure (ARF) following renal transplantation, according to a new study.
Naftopidil is effective first-line monotherapy for patients with storage symptoms associated with benign prostatic hyperplasia (BPH), according to researchers in Japan.
African-American (AA) men with nonpalpable prostate cancer have greater cancer volumes and higher prostatectomy Gleason scores than white men with similar PSA levels at the time of biopsy, according to a study.
Expression of cyclooxygenase-2 (COX-2) in prostate cancer tissue is an independent predictor of biochemical recurrence following radical prostatectomy.
Treatment with a gonadotropin-releasing hormone (GnRH) agonist is associated with increased risks of diabetes, coronary heart disease (CHD), MI, and sudden cardiac death in men with prostate cancer, according to an observational study at Harvard Medical School in Boston.
Glucose control influences glomerular filtration rate (GFR) and its estimations in patients with type 1 or 2 diabetes, a French study found.
Chronic kidney disease (CKD) is independently associated with an increased risk of ischemic stroke and transient ischemic attack (TIA) in patients with pre-existing atherothrombotic disease, new findings suggest.